Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Esomeprazole × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 6 Barrett Esophagus 6 Gastritis 4 Breast Neoplasms 4 Peptic Ulcer 3 Gastroesophageal Reflux 3 Dyspepsia 3 Zollinger-Ellison Syndrome 2 Stomach Ulcer 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Radiation Esophagitis 1 Precancerous Conditions 1 Peptic Ulcer Hemorrhage 1 Neoplasm Metastasis 1 Nausea 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Hot Flashes 1 Hemorrhage 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Esophagitis, Peptic 1 Esophagitis 1 Colonic Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Rituximab 133 Cyclophosphamide 124 fludarabine phosphate 71 Peripheral Blood Stem Cell Transplantation 63 Filgrastim 53 Radiotherapy 48 Whole-Body Irradiation 47 Mycophenolic Acid 47 Lenalidomide 45 Cyclosporine 45 Etoposide 40 Busulfan 35 Tacrolimus 33 Antilymphocyte Serum 32 Melphalan 30 fludarabine 27 Methotrexate 25 Prednisone 23 Bendamustine Hydrochloride 23 Cytarabine 21 Bortezomib 21 Vincristine 19 obinutuzumab 18 ibrutinib 18 Cord Blood Stem Cell Transplantation 18 Methylprednisolone 17 Flow Cytometry 17 venetoclax 15 Granulocyte Colony-Stimulating Factor 15 Doxorubicin 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07144657 2025-08-27

GastricMALToma

National Taiwan University Hospital

Phase 2 Not yet recruiting

Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡